Medical credit cards provide patients with essential support. Here are 3 tips to help you steer clear of common pitfalls.

Written by Emily J. Thompson, Senior Investment Analyst

Source: MarketWatch

Updated: Sep 25 2025

0mins

SNBR+4.74%

WFC+0.9%

SYF+1.79%

Should l Buy SNBR?

Source: MarketWatch

Medical Credit Card Usage: Sandra Lynn, a Texas resident, opened a medical credit card to cover the costs of root canals not covered by her insurance, avoiding the use of her savings.
Credit Limit Issues: After using the card for the first procedure, she was informed that she needed to pay off the balance before using it again, highlighting a lack of clarity regarding the card's terms.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy SNBR?" and start using high-conviction signals backed by rigorous historical data.

SNBR

$12.37+Infinity%1D

Analyst Views on SNBR

Wall Street analysts forecast SNBR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNBR is 5.50 USD with a low forecast of 5.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Analyst Rating

0 Buy

2 Hold

0 Sell

Hold

Current: 11.810

Low

5.00

Averages

5.50

High

6.00

Current: 11.810

Low

5.00

Averages

5.50

High

6.00

Piper Sandler

Neutral

maintain

$5 -> $12

2026-01-16

Reason

Piper Sandler

Price Target

$5 -> $12

AI Analysis

2026-01-16

maintain

Neutral

Reason

Piper Sandler raised the firm's price target on Sleep Number to $12 from $5 and keeps a Neutral rating on the shares. The firm notes that while Sleep Number didn't pre-announce Q4 results, Piper had a chance to spend time with new CEO Linda Findley, and it walked away impressed and believes she represents a significant upgrade from her predecessor.

UBS

Neutral

downgrade

$7 -> $6

2025-11-06

Reason

UBS

Price Target

$7 -> $6

2025-11-06

downgrade

Neutral

Reason

UBS lowered the firm's price target on Sleep Number to $6 from $7 and keeps a Neutral rating on the shares.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for SNBR

Unlock Now

About SNBR

Sleep Number Corporation is a wellness technology company. The Company is engaged in designing, manufacturing, marketing, and distribution of sleep solutions. Its wellness technology platform helps solve sleep problems, whether it’s providing individualized temperature control for each sleeper through its Climate360 smart bed or applying its 24 billion hours of longitudinal sleep data and expertise to research with global institutions. The Company’s smart beds provide unmatched features, benefits and comfort that can lead to improved sleep health and wellness for both sleepers. Its active temperature balancing technology supports the ideal climate for both sleepers and solves a prevalent sleep challenge. The Company’s smart bed ecosystem includes a full line of FlexFit smart adjustable bases that seamlessly integrate with Sleep Number smart beds for an individualized sleep experience that is proven to deliver more restful sleep per night.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Travis Kelce Becomes Minority Shareholder in Sleep Number

Jan 28 2026stocktwits

Shareholder Structure Change: Travis Kelce will acquire Sleep Number common stock on the open market and receive restricted stock units, maintaining total ownership below 5%, yet becoming one of the company's top shareholders, thereby strengthening its shareholder base.
Positive Market Reaction: Following the announcement of Kelce's minority stake, Sleep Number's shares jumped over 10% after the opening bell on Wednesday, indicating market optimism about the collaboration and reflecting investor confidence in the brand's ability to attract younger consumers.
Marketing Strategy Enhancement: Kelce will participate in Sleep Number's national marketing campaigns over the next three years, including television commercials and digital content, which is expected to drive sales growth, especially significant given the 19.6% decline in sales during the third quarter.
NFL Partnership Deepening: This collaboration further solidifies Sleep Number's long-standing partnership with the NFL, of which it has been an official partner since 2018, and Kelce's involvement is anticipated to enhance brand visibility and influence among sports fans.

Travis Kelce Joins Sleep Number as Investor and Strategic Partner

Jan 28 2026seekingalpha

Celebrity Investor Joins: NFL star Travis Kelce becomes a new investor and strategic partner for Sleep Number (SNBR), acquiring common stock on the open market and receiving restricted stock units, positioning him as one of the top shareholders with under 5% ownership, thereby aligning his interests with those of all shareholders.
Advertising Collaboration: Over the next three years, Kelce will feature in Sleep Number's national advertising campaigns, including new TV commercials and digital content, which is expected to significantly enhance brand visibility and attract more consumer attention.
Long-term Customer Trust: A loyal Sleep Number user since 2019, Kelce noted that the ability to adjust his bed according to recovery needs made investing a natural next step, highlighting the deep connection between the brand and its users.
NFL Partnership Continuation: Since 2018, Sleep Number has been the Official Sleep + Wellness Partner of the NFL, and Kelce's involvement is seen as a natural extension of this relationship, likely to further boost the brand's influence among athletes and fans.

Sleep Number Appoints Amy O'Keefe as Chief Financial Officer

Dec 02 2025NASDAQ.COM

New CFO Appointment: Sleep Number Corp. has appointed Amy O'Keefe as the new chief financial officer, effective December 8, succeeding interim CFO Bob Ryder.
CFO Background: O'Keefe brings over 30 years of experience in financial leadership across various sectors, most recently serving as the Chief Financial and Administrative Officer at Avaya.
Fiscal Guidance Reaffirmed: The company has reaffirmed its fiscal 2025 guidance, expecting net sales of approximately $1.4 billion, a gross profit margin of around 60%, and adjusted EBITDA of about $70 million.
Stock Performance: In pre-market trading, Sleep Number shares were up 1.91%, priced at $5.86 on the Nasdaq.

Sleep Number (SNBR): Significant Discounts Highlight Turnaround Potential Amidst Weak Margins

Nov 06 2025Yahoo Finance

Current Financial Status: Sleep Number (SNBR) is experiencing losses with no immediate signs of margin improvement, forecasting a revenue growth of only 3.6% annually compared to the broader market's 10.5%.
Future Earnings Projections: Despite current challenges, analysts predict a significant turnaround with earnings expected to grow by 97.54% per year over the next three years, alongside a projected increase in profit margins from -2.7% to 1.6%.
Debt and Financial Constraints: The company faces a high debt burden and lacks positive equity, which limits its ability to invest and adapt, raising concerns about its long-term financial health and innovation potential.
Valuation and Investment Outlook: Trading at $5.29, Sleep Number's stock is significantly undervalued compared to its estimated fair value of $21.86, attracting deep value investors, though many remain cautious due to weak fundamentals and the absence of near-term growth catalysts.